Project Grant HT94252311081
Award Date 9/30/23
Completion Date 9/29/27
Dollars Obligated $3.8M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
- This federal Project Grant award, valued at $3,618,191.00 and issued on July 1, 2024, is funded by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The award supports the development of a portable hemodialysis device to facilitate home use and field implementation. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will lead the research and development efforts. This includes optimizing a...
- This Project Grant award of $1,412,000 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a biorepository and community development project to characterize aggressive urothelial cancer variants. The University of Washington, as the prime awardee, will conduct this research over a period of approximately 4 years, from September 2024 through August 2028. The project aims to expand understanding of aggressive forms of urothelial (bladder)...
- The U.S. Defense Health Agency awarded a $1,927,410.00 Project Grant to the University of Washington for the "CONTRAST-ENHANCED ULTRASOUND BIOMARKER FOR PROGNOSTICATION AND GUIDANCE OF SURGICAL TREATMENT IN ACUTE TRAUMATIC SPINAL CORD INJURY" project. The grant was awarded on August 31, 2023 and is scheduled for completion on August 30, 2026. This project falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced...
- The Defense Health Agency (DHA) awarded the University of Washington a $543,285 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2028. This award supports research focused on transforming rhabdomyosarcoma treatment through the development and evaluation of new FDA-approved combination therapies. The project will be conducted at the University of Washington's Seattle, Washington location under the...
- The University of Washington received a $622,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the fibrolamellar carcinoma tumor microenvironment using human tumor slice cultures. The award has a performance period from July 1, 2024 to June 30, 2026. Through this funding, the University of Washington will investigate innovative approaches to improve understanding of the fibrolamellar carcinoma tumor...
- This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
- This federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $1,749,465.00 to Bright Uro, Inc. to develop a catheter-free, extended-monitoring urodynamics device for quantitative, real-time bladder management in spinal cord-injured patients. The award period runs from July 1, 2024 to June 1, 2026. The goal of this project is to create an innovative medical device that can assist in the care and treatment...
- The federal Project Grant award of $932,918 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Washington to determine the role of somatic mosaicism in ovarian cancer predisposition. The grant, awarded on September 30, 2024 with an ultimate completion date of September 29, 2028, will enable the University of Washington to conduct innovative scientific studies to improve health outcomes for military...
- The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
- This federal Project Grant award of $1,383,874.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Maryland, Baltimore to decipher the intramolecular regulatory mechanism of polycystin 1, which is implicated in polycystic kidney disease. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the scientific understanding of this...